These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32036603)

  • 1. Janus or Hydra: The Many Faces of T Helper Cells in the Human Tumour Microenvironment.
    Guisier F; Barros-Filho MC; Rock LD; Strachan-Whaley M; Marshall EA; Dellaire G; Lam WL
    Adv Exp Med Biol; 2020; 1224():35-51. PubMed ID: 32036603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation and Regulation of T
    Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
    Front Immunol; 2021; 12():669474. PubMed ID: 34012451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of CD4(+) T cell help generates corrupt CD8(+) effector T cells in sarcoma-bearing Swiss mice treated with NLGP vaccine.
    Ghosh S; Sarkar M; Ghosh T; Guha I; Bhuniya A; Biswas J; Mallick A; Bose A; Baral R
    Immunol Lett; 2016 Jul; 175():31-9. PubMed ID: 27178306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of CD4+ helper T-cells in antitumor immunity.
    Shiku H
    Int J Hematol; 2003 Jun; 77(5):435-8. PubMed ID: 12841380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.
    Finn OJ
    Ann Oncol; 2012 Sep; 23 Suppl 8(Suppl 8):viii6-9. PubMed ID: 22918931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells.
    Xiang J; Huang H; Liu Y
    J Immunol; 2005 Jun; 174(12):7497-505. PubMed ID: 15944248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microenvironment abnormalities and lymphomagenesis: Immunological aspects.
    Taylor JG; Gribben JG
    Semin Cancer Biol; 2015 Oct; 34():36-45. PubMed ID: 26232774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapeutic efficacy of both helper T lymphocytes and cytotoxic T lymphocytes epitopes augmented dendritic cells tumor vaccine on gastric cancer].
    Li Q; Zhang Y; Chen XH; Cao WX; Gu QL; Zhu ZG; Liu BY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):148-51. PubMed ID: 16555158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T Cells and Cancer-Associated Inflammation: A New Direction for Immunotherapy?
    Dong C
    J Interferon Cytokine Res; 2017 Sep; 37(9):383-385. PubMed ID: 28727936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of immune responses by cloned T cells and their products.
    Tada T; Inoue T; Asano Y
    Behring Inst Mitt; 1992 Apr; (91):78-86. PubMed ID: 1388020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCR-ABL-specific CD4
    Ueda N; Zhang R; Tatsumi M; Liu TY; Kitayama S; Yasui Y; Sugai S; Iwama T; Senju S; Okada S; Nakatsura T; Kuzushima K; Kiyoi H; Naoe T; Kaneko S; Uemura Y
    Cell Mol Immunol; 2018 Jan; 15(1):15-26. PubMed ID: 27181332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes in cancer development: polarization towards pro-tumor immunity.
    Ruffell B; DeNardo DG; Affara NI; Coussens LM
    Cytokine Growth Factor Rev; 2010 Feb; 21(1):3-10. PubMed ID: 20005150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages.
    Duncan DD; Swain SL
    Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmenting T helper cell immunity in cancer.
    Knutson KL; Disis ML
    Curr Drug Targets Immune Endocr Metabol Disord; 2005 Dec; 5(4):365-71. PubMed ID: 16375690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating T Cell Immunity in Cancer: Achievements and Prospects.
    Zeng Z; Chew HY; Cruz JG; Leggatt GR; Wells JW
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy.
    Zhang M; Zhang L; Li H; Chen Z; Luo A; Liu B; Chen M; Peng M; Ren H; Hu P
    Int Immunopharmacol; 2016 May; 34():235-243. PubMed ID: 26971227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation with dendritic cells decreases or obviates the CD4+ helper cell requirement in cytotoxic T lymphocyte responses.
    Boog CJ; Boes J; Melief CJ
    Eur J Immunol; 1988 Feb; 18(2):219-23. PubMed ID: 2965021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic Reprogramming of CD4
    Renaude E; Kroemer M; Borg C; Peixoto P; Hervouet E; Loyon R; Adotévi O
    Front Immunol; 2021; 12():669992. PubMed ID: 34262562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.